Top Markets
#1 iExec RLC iExec RLC +24.11%
#2 API3 API3 +22.76%
#3 Bedrock Bedrock +20.73%
#4 CyberDEX CyberDEX +19.33%
#5 Radicle Radicle +18.96%
#6 Talus Network Talus Network +18.08%
#7 The Bitcoin Bull The Bitcoin Bull +16.95%
#8 VeThor VeThor +12.86%
#9 Orca Orca +11.81%
#10 Nockchain Nockchain +11.21%
Coin of the day
iExec RLC iExec RLC
Configurações
Idioma
PORTUGUêS
Moeda
USD
Tema
Cell Source, Inc. Cell Source, Inc.

Cell Source, Inc.

CLCS
Classificação em ações #28218
Cell Source, Inc. is a biotechnology firm dedicated to creating cell-based... Cell Source, Inc. is a biotechnology firm dedicated to creating cell-based therapies centered on regulating immune tolerance. The company's flagship innovation is its Veto Cell immune system management technology, an advanced immune tolerance platform capable of selectively suppressing specific immune responses. This Veto Cell technology finds application in numerous areas, including enhancing the acceptance of stem cell transplants for conditions like lymphoma, leukemia, and multiple myeloma. Furthermore, it is utilized in treating end-stage kidney disease, various other non-malignant organ diseases, and a spectrum of both cancerous and non-malignant illnesses. Founded in 2012, Cell Source, Inc. maintains its corporate headquarters in New York, New York.
Preço da ação
$0.4
Última sincronização: 2026-10-02
Valor de mercado
$27.18M
Variação (1 dia)
-14.88%
Variação (1 ano)
8.11%
País
US
Negociar Cell Source, Inc. (CLCS)

Categoria

Healthcare
EPS de Cell Source, Inc. (CLCS)
EPS em 2026 TTM: 0
De acordo com os últimos relatórios financeiros e o preço das ações da Cell Source, Inc., o EPS atual da empresa (TTM) é 0. No final de 2026, a empresa teve um EPS de 0, igual a ao EPS de 2026, que foi de 0.
Histórico de EPS da Cell Source, Inc. de 2026 até 2026
EPS no final de cada ano
Ano EPS Alterar
Não há dados suficientes para as datas fornecidas.
EPS de empresas semelhantes ou concorrentes
Empresa EPS Diferença de EPS País
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $17.32 -
US
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $-7.98 -
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $-5.29 -
AU
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $27.74 -
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH